Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
December 31, 2019
Patent Application Number
15328288
Date Filed
July 24, 2015
Patent Citations Received
Patent Primary Examiner
Patent abstract
Provided herein are compositions, methods, and uses involving bispecific binding molecules that specifically bind to HER2, a receptor tyrosine kinase, and to CD3, a T cell receptor, and mediate T cell cytotoxicity for managing and treating disorders, such as cancer. Also provided herein are uses and methods for managing and treating HER2-related cancers.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
